Role of chronotype in depression

Table 4 Therapeutic implications/strategies for depression based on chronotype

Therapeutic approach	Core mechanism	Chronotype-specific considerations	Limitations/challenges
Light therapy	Resets circadian rhythms by modulating light exposure at specific times	Evening chronotypes show better response to morning light therapy; morning chronotypes may benefit from afternoon light	Short-term effects were demonstrated; long-term stability unconfirmed; chronotype may revert after intervention; optimal timing, intensity, and wavelength remain undefined
CBT	Modifies behavior/Lifestyle to align with chronotype or shift sleep-wake timing	Evening chronotypes may require gradual sleep-wake advancement protocols; CBT timing (e.g., afternoon sessions) may influence chronotype shifts	Lack of long-term data on mood stability; need for personalized CBT components (e.g., sleep restriction)
Pharmacotherapy	Antidepressant efficacy varies with chronotype due to interactions between circadian rhythms and neurotransmitters	Evening chronotypes may be suitable for sedative antidepressants (e.g., mirtazapine) dosed at bedtime; morning chronotypes may benefit from activating SSRIs (e.g., fluoxetine) in the morning	Limited research on chronotype-pharmacokinetics interactions; inconsistent findings across studies; need for personalized dosing based on genes (e.g., PER3 and CYP450)
Lifestyle interventions	Regular exercise and structured routines synchronize circadian rhythms	Avoid nocturnal exercise in evening chronotypes; prioritize morning physical activity	Limited evidence on chronotype-tailored exercise protocols; the synergy between interventions remains unclear
Combined interventions	Multimodal approaches targeting circadian alignment and neurotransmitter systems	Tailor combinations to chronotype (e.g., morning light + CBT for evening chronotypes)	Complexity of implementing multimodal protocols; long-term adherence and efficacy data are needed; individual variability

CBT: Cognitive behavioral therapy; SSRIs: Selective serotonin reuptake inhibitors.